YOUNGY HEALTH CO., LTD. Financials Youngy Health Co., Ltd.
Equities
300247
CNE1000015V4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.07 CNY | +0.66% |
|
+7.72% | -13.76% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,760 | 2,275 | 2,155 | 3,715 | 2,854 | 2,862 |
| Enterprise Value (EV) 1 | 2,682 | 2,101 | 1,913 | 3,463 | 2,358 | 2,263 |
| P/E ratio | -3.46 x | -3.18 x | -33.5 x | 154 x | 22.2 x | 119 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 2.6 x | 3.12 x | 4.19 x | 7.06 x | 6.16 x | 5.41 x |
| EV / Revenue | 2.52 x | 2.88 x | 3.72 x | 6.58 x | 5.09 x | 4.27 x |
| EV / EBITDA | -23.4 x | -9.99 x | 62.6 x | 118 x | 436 x | 45.2 x |
| EV / FCF | -168 x | 14.2 x | 43.5 x | 67.8 x | -82.9 x | 28.1 x |
| FCF Yield | -0.6% | 7.03% | 2.3% | 1.48% | -1.21% | 3.56% |
| Price to Book | 1.74 x | 2.6 x | 2.67 x | 4.47 x | 2.89 x | 2.81 x |
| Nbr of stocks (in thousands) | 804,542 | 804,040 | 804,040 | 804,040 | 804,040 | 804,040 |
| Reference price 2 | 3.430 | 2.830 | 2.680 | 4.620 | 3.550 | 3.560 |
| Announcement Date | 19-04-29 | 20-04-23 | 21-04-20 | 22-04-24 | 23-04-25 | 24-04-23 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,063 | 730.2 | 514.1 | 526.5 | 463.3 | 529.4 |
| EBITDA 1 | -114.7 | -210.3 | 30.57 | 29.44 | 5.404 | 50.11 |
| EBIT 1 | -145.3 | -241.4 | 12.39 | 12.29 | -12.81 | 32.94 |
| Operating Margin | -13.67% | -33.06% | 2.41% | 2.33% | -2.77% | 6.22% |
| Earnings before Tax (EBT) 1 | -772.3 | -722.9 | -45.56 | 37.77 | 136.4 | 59.76 |
| Net income 1 | -782.2 | -716.1 | -65.73 | 24.2 | 126.3 | 26.58 |
| Net margin | -73.56% | -98.07% | -12.79% | 4.6% | 27.26% | 5.02% |
| EPS 2 | -0.9900 | -0.8900 | -0.0800 | 0.0300 | 0.1600 | 0.0300 |
| Free Cash Flow 1 | -15.98 | 147.8 | 43.94 | 51.11 | -28.46 | 80.67 |
| FCF margin | -1.5% | 20.24% | 8.55% | 9.71% | -6.14% | 15.24% |
| FCF Conversion (EBITDA) | - | - | 143.77% | 173.62% | - | 161% |
| FCF Conversion (Net income) | - | - | - | 211.17% | - | 303.48% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-04-29 | 20-04-23 | 21-04-20 | 22-04-24 | 23-04-25 | 24-04-23 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 77.3 | 174 | 242 | 252 | 496 | 599 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -16 | 148 | 43.9 | 51.1 | -28.5 | 80.7 |
| ROE (net income / shareholders' equity) | -39.7% | -57.9% | -6.42% | 3.72% | 14.1% | 3.99% |
| ROA (Net income/ Total Assets) | -3.63% | -9.57% | 0.74% | 0.78% | -0.72% | 1.71% |
| Assets 1 | 21,566 | 7,484 | -8,871 | 3,118 | -17,424 | 1,558 |
| Book Value Per Share 2 | 1.970 | 1.090 | 1.010 | 1.030 | 1.230 | 1.260 |
| Cash Flow per Share 2 | 0.2200 | 0.1100 | 0.2000 | 0.1100 | 0.0800 | 0.1500 |
| Capex 1 | 28.9 | 23.1 | 8.69 | 6.22 | 17.5 | 7.88 |
| Capex / Sales | 2.72% | 3.17% | 1.69% | 1.18% | 3.78% | 1.49% |
| Announcement Date | 19-04-29 | 20-04-23 | 21-04-20 | 22-04-24 | 23-04-25 | 24-04-23 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.76% | 339M | |
| +73.46% | 12.41B | |
| -16.75% | 7.87B | |
| +5.93% | 6.37B | |
| +3.66% | 5.81B | |
| +13.79% | 5.36B | |
| +40.99% | 4.92B | |
| -19.73% | 4.02B | |
| -34.55% | 2.43B | |
| +0.74% | 2.02B |
- Stock Market
- Equities
- 300247 Stock
- Financials Youngy Health Co., Ltd.